Update On Phase Ib Trial Of Avid200 In Myelofibrosis

2022 3:02
Synopsis
Ronald Hoffman, MD, Icahn School of Medicine at Mount Sinai, New York, NY, explains the rationale and gives an update on the ...

You Might Also Like

Phase Ib trial of AVID200 in refractory myelofibrosis 4:15
Phase Ib Trial Of Avid200 In Refractory Myelofibrosis
2021
Adam Mead, MD, on PROMise trial updates in myelofibrosis 4:35
Adam Mead, Md, On Promise Trial Updates In Myelofibrosis
2025
Redefining End Points in Myelofibrosis Clinical Trials 3:10
Redefining End Points In Myelofibrosis Clinical Trials
2025
Phase I/II trial of tagraxofusp in poor-risk myelofibrosis 2:43
Phase I/ii Trial Of Tagraxofusp In Poor-risk Myelofibrosis
2020
Phase Ib trial of ivosidenib plus ruxolitinib in IDH1-mutated advanced MPNs 2:05
Phase Ib Trial Of Ivosidenib Plus Ruxolitinib In Idh1-mutate...
2025
An update of IMproveMF: dose-escalation of imetelstat + ruxolitinib in patients with myelofibrosis 2:46
An Update Of Improvemf: Dose-escalation Of Imetelstat + Ruxo...
2025
Phase I study of ruxolitinib plus abemaciclib for patients with myelofibrosis 1:01
Phase I Study Of Ruxolitinib Plus Abemaciclib For Patients W...
2023
A Phase Ib trial investigating the combination of ruxolitinib and duvelisib in R/R T-cell lymphoma 1:52
A Phase Ib Trial Investigating The Combination Of Ruxolitini...
2025
A Phase Ib trial of fixed-volume isatuximab infusion in newly-diagnosed multiple myeloma 3:28
A Phase Ib Trial Of Fixed-volume Isatuximab Infusion In Newl...
2020
A Phase I/II trial of iberdomide for the treatment of intermediate- or high-risk smoldering myeloma 2:28
A Phase I/ii Trial Of Iberdomide For The Treatment Of Interm...
2025
Phase II trial-in-progress of itacitinib in patients with myelofibrosis 1:49
Phase Ii Trial-in-progress Of Itacitinib In Patients With My...
2021
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.